First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
On Feb. 27, 2020, a consortium of philanthropic, non-profit and private sector organisations launched a collaboration that aims…
Biotechnology | COVID-19 | Diagnostics | Disease | Genomics | Life Science News | Non-Profit Research | Therapeutics
Innovation Pharma shipped Brilacidin to U.S. Regional Biocontainment Laboratory for research against Coronavirus COVID-19
On Feb. 27, 2020, Innovation Pharma announced the Company had signed a Material Transfer Agreement (MTA) with one…
NIH announced $1 million prize competition to target global disease diagnostics
On Feb. 25, 2020, the U. S. National Institutes of Health (NIH) announced it had launched a $1…
Georgia Tech and Shriners Hospitals for Children announced new collaborative research affiliation
On Feb. 26, 2020, Georgia Institute of Technology and Shriners Hospitals for Children announced a collaborative research affiliation…
Novavax advanced development of novel COVID-19 vaccine
On Feb. 26, 2020, Novavax announced progress in its efforts to develop a novel vaccine to protect against…
New images of novel Coronavirus SARS-CoV-2 made available
On Feb. 26, 2020, the National Institute of Allergy and Infectious Diseases’ Rocky Mountain Laboratories (NIAID-RML) announced it…
Tonix Pharma announced collaboration with Southern Research to develop vaccine to protect against COVID-19 based on Horsepox virus
On Feb. 26, 2020, Tonix Pharmaceuticals announced a strategic collaboration with Southern Research to support the development of…
NIH clinical trial of remdesivir to treat COVID-19 began for adults with coronavirus disease
On Feb. 25, 2020, the National Institutes of Health (NIH) announced that a randomized, controlled clinical trial to…
Cherokee Nation became first U.S .tribe to preserve culturally important seeds in the Svalbard Global Seed Vault
On Feb. 25, 2020, the Cherokee Nation became the first U.S. tribe to preserve culturally important seeds in…
Pilot clinical trial in China to test University of British Columbia researcher’s findings as a targeted therapy for COVID-19
On Feb. 25, 2020, a University of British Columbia researcher was part of an international team working with…
Vir Biotec and WuXi Biologics announced collaboration for global development of antibodies to treat COVID-19
On Feb. 25, 2020, Vir Biotech announced a development and manufacturing collaboration to advance and produce human monoclonal…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
New technique helped uncover how Coronaviruses enter cells
On Feb. 24, 2020, researchers at National Institute of Allergy and Infectious Disease’s Rocky Mountain Laboratories in Hamilton,…
Clover and GSK announced research collaboration to evaluate Coronavirus vaccine candidate with pandemic adjuvant system
On Feb. 24, 2020, Clover Biopharmaceuticals announced a research collaboration with GSK for its protein-based coronavirus vaccine candidate…
Innovation Pharma submited Material Transfer Agreement to study defensin mimetic Brilacidin for Coronavirus
On Feb. 24, 2020, Innovation Pharmaannounced the Company submitted a Material Transfer Agreement (MTA) with a leading U.S.-based…
Moderna shipped mRNA vaccine against novel Coronavirus (mRNA-1273) for phase 1 study
On Feb. 24, 2020, Moderna announced it had released the first batch of mRNA-1273, the Company’s vaccine against…
Texas Biomed established team to study SARS-CoV-2, new coronavirus
On Feb. 24, 2020, Scientists at Texas Biomed began work on the novel coronavirus known as SARS-CoV-2. A…
FDA approved Fluad Quadrivalent (influenza vaccine, adjuvanted; Seqirus) for adults 65 years and older
On Feb. 24, 2020, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved the first…
FDA | Life Science News | NIH | U.S. Congress
Federal Judge ruled missing clinical trial data must be made public
On Feb. 22, 2020, a federal judge from the Southern District of New York ruled drug companies, device…
FDA approved Lundbeck’s VYEPTI™ – the first and only intravenous preventive treatment for migraine
On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…
The FDA approved non-statin drug to treat high cholesterol
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) approved NEXLETOL (bempedoic acid) tablet, an oral,…
University of Missouri alumni gave $2 million gift to NextGen Precision Health Institute
On Feb. 21, 2020, a $2 million gift from University of Missouri alumni will support the university’s NextGen…
FDA authorized marketing of first genetic test to aid in diagnosis of Fragile X Syndrome
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) authorized marketing of the first test to…
COVID-19 coronavirus spike holds infectivity details
On Feb. 24, 2020, researchers reported that the spikes crowning the new coronavirus that causes COVID-19 atypical pneumonia…
Artificial Intelligence | Biotechnology | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
Artificial intelligence yielded new antibiotic
On Feb. 20, 2020, using a machine-learning algorithm, researchers at MIT and the Broad Institute of MIT and…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics
Tim and Mary Boyle gave $10 million to OHSU for joint center for biomedical data science
On Feb. 20, 2020, Tim Boyle, CEO of Columbia Sportswear, and his wife, Mary, made a $10 million…
NIH scientists identified atomic structure of novel Coronavirus protein
On Feb. 19, 2020, NIAID scientists working with investigators from the University of Texas at Austin identified the…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Therapeutics | Vaccine
The CPRIT awarded 55 new grants totaling over $78 million
On Feb. 19, 2020, Cancer Prevention & Research Institute of Texas (CPRIT) announced it had awarded 55 grants…
Sanofi joined with U.S. Dept of Health and Human Services to advance novel coronavirus vaccine
On Feb. 18, 2020, Sanofi announced it had leveraged previous development work for a SARS vaccine which may…
Innovation Pharma’s Brilacidin tested as drug and vaccine at different institutions
On Feb. 18, 2020, Innovation Pharma announced the Company was exploring its lead defensin mimetic drug candidate, Brilacidin,…
COVID-19 | Life Science News | NIH | Vaccine
Medigen Vaccine Biologics and NIH collaborated to develop COVID-19 vaccine
On Feb. 16, 2020, Medigen Vaccine Biologics (MVB) and the National Institutes of Health (NIH) announced they had…